Estradiol Patch Matches Standard Hormone Therapy in Phase 3 Trial: A New First-Line Option for Menopause episode artwork

EPISODE · May 6, 2026 · 1 MIN

Estradiol Patch Matches Standard Hormone Therapy in Phase 3 Trial: A New First-Line Option for Menopause

from TheBrief.Health · host TheBrief.Health

Estradiol patch shows comparable efficacy to oral hormone therapy for menopause symptoms, offering a convenient transdermal option that may improve safety, adherence, and personalized treatment choices.

Episode metadata supplied by the publisher feed · Published May 6, 2026

Embed this episode

NOW PLAYING

Estradiol Patch Matches Standard Hormone Therapy in Phase 3 Trial: A New First-Line Option for Menopause

0:00 1:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 6, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!